Study of Sirolimus in Patients With Advanced Pancreatic Cancer

NCT03662412 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Sirolimus

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University